Cargando…
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
RATIONALE: Asthma phenotyping requires novel biomarker discovery. OBJECTIVES: To identify plasma biomarkers associated with asthma phenotypes by application of a new proteomic panel to samples from two well-characterised cohorts of severe (SA) and mild-to-moderate (MMA) asthmatics, COPD subjects and...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850689/ https://www.ncbi.nlm.nih.gov/pubmed/34737220 http://dx.doi.org/10.1183/13993003.00142-2021 |
_version_ | 1784652654440349696 |
---|---|
author | Sparreman Mikus, Maria Kolmert, Johan Andersson, Lars I. Östling, Jörgen Knowles, Richard G. Gómez, Cristina Ericsson, Magnus Thörngren, John-Olof Emami Khoonsari, Payam Dahlén, Barbro Kupczyk, Maciej De Meulder, Bertrand Auffray, Charles Bakke, Per S. Beghe, Bianca Bel, Elisabeth H. Caruso, Massimo Chanez, Pascal Chawes, Bo Fowler, Stephen J. Gaga, Mina Geiser, Thomas Gjomarkaj, Mark Horváth, Ildikó Howarth, Peter H. Johnston, Sebastian L. Joos, Guy Krug, Norbert Montuschi, Paolo Musial, Jacek Niżankowska-Mogilnicka, Ewa Olsson, Henric K. Papi, Alberto Rabe, Klaus F. Sandström, Thomas Shaw, Dominick E. Siafakas, Nikolaos M. Uhlén, Mathias Riley, John H. Bates, Stewart Middelveld, Roelinde J.M. Wheelock, Craig E. Chung, Kian Fan Adcock, Ian M. Sterk, Peter J. Djukanovic, Ratko Nilsson, Peter Dahlén, Sven-Erik James, Anna |
author_facet | Sparreman Mikus, Maria Kolmert, Johan Andersson, Lars I. Östling, Jörgen Knowles, Richard G. Gómez, Cristina Ericsson, Magnus Thörngren, John-Olof Emami Khoonsari, Payam Dahlén, Barbro Kupczyk, Maciej De Meulder, Bertrand Auffray, Charles Bakke, Per S. Beghe, Bianca Bel, Elisabeth H. Caruso, Massimo Chanez, Pascal Chawes, Bo Fowler, Stephen J. Gaga, Mina Geiser, Thomas Gjomarkaj, Mark Horváth, Ildikó Howarth, Peter H. Johnston, Sebastian L. Joos, Guy Krug, Norbert Montuschi, Paolo Musial, Jacek Niżankowska-Mogilnicka, Ewa Olsson, Henric K. Papi, Alberto Rabe, Klaus F. Sandström, Thomas Shaw, Dominick E. Siafakas, Nikolaos M. Uhlén, Mathias Riley, John H. Bates, Stewart Middelveld, Roelinde J.M. Wheelock, Craig E. Chung, Kian Fan Adcock, Ian M. Sterk, Peter J. Djukanovic, Ratko Nilsson, Peter Dahlén, Sven-Erik James, Anna |
author_sort | Sparreman Mikus, Maria |
collection | PubMed |
description | RATIONALE: Asthma phenotyping requires novel biomarker discovery. OBJECTIVES: To identify plasma biomarkers associated with asthma phenotypes by application of a new proteomic panel to samples from two well-characterised cohorts of severe (SA) and mild-to-moderate (MMA) asthmatics, COPD subjects and healthy controls (HCs). METHODS: An antibody-based array targeting 177 proteins predominantly involved in pathways relevant to inflammation, lipid metabolism, signal transduction and extracellular matrix was applied to plasma from 525 asthmatics and HCs in the U-BIOPRED cohort, and 142 subjects with asthma and COPD from the validation cohort BIOAIR. Effects of oral corticosteroids (OCS) were determined by a 2-week, placebo-controlled OCS trial in BIOAIR, and confirmed by relation to objective OCS measures in U-BIOPRED. RESULTS: In U-BIOPRED, 110 proteins were significantly different, mostly elevated, in SA compared to MMA and HCs. 10 proteins were elevated in SA versus MMA in both U-BIOPRED and BIOAIR (alpha-1-antichymotrypsin, apolipoprotein-E, complement component 9, complement factor I, macrophage inflammatory protein-3, interleukin-6, sphingomyelin phosphodiesterase 3, TNF receptor superfamily member 11a, transforming growth factor-β and glutathione S-transferase). OCS treatment decreased most proteins, yet differences between SA and MMA remained following correction for OCS use. Consensus clustering of U-BIOPRED protein data yielded six clusters associated with asthma control, quality of life, blood neutrophils, high-sensitivity C-reactive protein and body mass index, but not Type-2 inflammatory biomarkers. The mast cell specific enzyme carboxypeptidase A3 was one major contributor to cluster differentiation. CONCLUSIONS: The plasma proteomic panel revealed previously unexplored yet potentially useful Type-2-independent biomarkers and validated several proteins with established involvement in the pathophysiology of SA. |
format | Online Article Text |
id | pubmed-8850689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-88506892022-02-18 Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation Sparreman Mikus, Maria Kolmert, Johan Andersson, Lars I. Östling, Jörgen Knowles, Richard G. Gómez, Cristina Ericsson, Magnus Thörngren, John-Olof Emami Khoonsari, Payam Dahlén, Barbro Kupczyk, Maciej De Meulder, Bertrand Auffray, Charles Bakke, Per S. Beghe, Bianca Bel, Elisabeth H. Caruso, Massimo Chanez, Pascal Chawes, Bo Fowler, Stephen J. Gaga, Mina Geiser, Thomas Gjomarkaj, Mark Horváth, Ildikó Howarth, Peter H. Johnston, Sebastian L. Joos, Guy Krug, Norbert Montuschi, Paolo Musial, Jacek Niżankowska-Mogilnicka, Ewa Olsson, Henric K. Papi, Alberto Rabe, Klaus F. Sandström, Thomas Shaw, Dominick E. Siafakas, Nikolaos M. Uhlén, Mathias Riley, John H. Bates, Stewart Middelveld, Roelinde J.M. Wheelock, Craig E. Chung, Kian Fan Adcock, Ian M. Sterk, Peter J. Djukanovic, Ratko Nilsson, Peter Dahlén, Sven-Erik James, Anna Eur Respir J Original Research Articles RATIONALE: Asthma phenotyping requires novel biomarker discovery. OBJECTIVES: To identify plasma biomarkers associated with asthma phenotypes by application of a new proteomic panel to samples from two well-characterised cohorts of severe (SA) and mild-to-moderate (MMA) asthmatics, COPD subjects and healthy controls (HCs). METHODS: An antibody-based array targeting 177 proteins predominantly involved in pathways relevant to inflammation, lipid metabolism, signal transduction and extracellular matrix was applied to plasma from 525 asthmatics and HCs in the U-BIOPRED cohort, and 142 subjects with asthma and COPD from the validation cohort BIOAIR. Effects of oral corticosteroids (OCS) were determined by a 2-week, placebo-controlled OCS trial in BIOAIR, and confirmed by relation to objective OCS measures in U-BIOPRED. RESULTS: In U-BIOPRED, 110 proteins were significantly different, mostly elevated, in SA compared to MMA and HCs. 10 proteins were elevated in SA versus MMA in both U-BIOPRED and BIOAIR (alpha-1-antichymotrypsin, apolipoprotein-E, complement component 9, complement factor I, macrophage inflammatory protein-3, interleukin-6, sphingomyelin phosphodiesterase 3, TNF receptor superfamily member 11a, transforming growth factor-β and glutathione S-transferase). OCS treatment decreased most proteins, yet differences between SA and MMA remained following correction for OCS use. Consensus clustering of U-BIOPRED protein data yielded six clusters associated with asthma control, quality of life, blood neutrophils, high-sensitivity C-reactive protein and body mass index, but not Type-2 inflammatory biomarkers. The mast cell specific enzyme carboxypeptidase A3 was one major contributor to cluster differentiation. CONCLUSIONS: The plasma proteomic panel revealed previously unexplored yet potentially useful Type-2-independent biomarkers and validated several proteins with established involvement in the pathophysiology of SA. European Respiratory Society 2022-02-17 /pmc/articles/PMC8850689/ /pubmed/34737220 http://dx.doi.org/10.1183/13993003.00142-2021 Text en Copyright ©The authors 2022. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Original Research Articles Sparreman Mikus, Maria Kolmert, Johan Andersson, Lars I. Östling, Jörgen Knowles, Richard G. Gómez, Cristina Ericsson, Magnus Thörngren, John-Olof Emami Khoonsari, Payam Dahlén, Barbro Kupczyk, Maciej De Meulder, Bertrand Auffray, Charles Bakke, Per S. Beghe, Bianca Bel, Elisabeth H. Caruso, Massimo Chanez, Pascal Chawes, Bo Fowler, Stephen J. Gaga, Mina Geiser, Thomas Gjomarkaj, Mark Horváth, Ildikó Howarth, Peter H. Johnston, Sebastian L. Joos, Guy Krug, Norbert Montuschi, Paolo Musial, Jacek Niżankowska-Mogilnicka, Ewa Olsson, Henric K. Papi, Alberto Rabe, Klaus F. Sandström, Thomas Shaw, Dominick E. Siafakas, Nikolaos M. Uhlén, Mathias Riley, John H. Bates, Stewart Middelveld, Roelinde J.M. Wheelock, Craig E. Chung, Kian Fan Adcock, Ian M. Sterk, Peter J. Djukanovic, Ratko Nilsson, Peter Dahlén, Sven-Erik James, Anna Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation |
title | Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation |
title_full | Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation |
title_fullStr | Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation |
title_full_unstemmed | Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation |
title_short | Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation |
title_sort | plasma proteins elevated in severe asthma despite oral steroid use and unrelated to type-2 inflammation |
topic | Original Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850689/ https://www.ncbi.nlm.nih.gov/pubmed/34737220 http://dx.doi.org/10.1183/13993003.00142-2021 |
work_keys_str_mv | AT sparremanmikusmaria plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT kolmertjohan plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT anderssonlarsi plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT ostlingjorgen plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT knowlesrichardg plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT gomezcristina plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT ericssonmagnus plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT thorngrenjohnolof plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT emamikhoonsaripayam plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT dahlenbarbro plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT kupczykmaciej plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT demeulderbertrand plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT auffraycharles plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT bakkepers plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT beghebianca plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT belelisabethh plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT carusomassimo plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT chanezpascal plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT chawesbo plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT fowlerstephenj plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT gagamina plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT geiserthomas plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT gjomarkajmark plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT horvathildiko plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT howarthpeterh plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT johnstonsebastianl plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT joosguy plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT krugnorbert plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT montuschipaolo plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT musialjacek plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT nizankowskamogilnickaewa plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT olssonhenrick plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT papialberto plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT rabeklausf plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT sandstromthomas plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT shawdominicke plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT siafakasnikolaosm plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT uhlenmathias plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT rileyjohnh plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT batesstewart plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT middelveldroelindejm plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT wheelockcraige plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT chungkianfan plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT adcockianm plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT sterkpeterj plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT djukanovicratko plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT nilssonpeter plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT dahlensvenerik plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation AT jamesanna plasmaproteinselevatedinsevereasthmadespiteoralsteroiduseandunrelatedtotype2inflammation |